Goldman Sachs Maintains Bullish Stance on Biogen (BIIB), Sees Room for Significant Upside

Go back to Goldman Sachs Maintains Bullish Stance on Biogen (BIIB), Sees Room for Significant Upside
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 216.78 +2.43 (1.13%)
Previous Close $214.35    52 Week High $333.65 
Open $217.76    52 Week Low $223.02 
Day High $219.12    P/E 27.76 
Day Low $215.00    EPS $7.81 
Volume 722,348